Denne siden ble automatisk oversatt og nøyaktigheten av oversettelsen er ikke garantert. Vennligst referer til engelsk versjon for en kildetekst.

Exercise-Based Sensorimotor Physiotherapy for Postpartum Pelvic Health and Functional Recovery

9. juli 2026 oppdatert av: Özge BAYKAN ÇOPUROĞLU

Effects of a 12-Week Exercise-Based Sensorimotor Physiotherapy Program on Postpartum Pelvic Health and Functional Recovery: A Stratified Randomized Controlled Trial

This study evaluated whether a 12-week exercise-based sensorimotor physiotherapy program could improve pelvic health and functional recovery in postpartum women. Participants were women aged 18-40 years who were between 6 weeks and 6 months after a singleton delivery. They were randomly assigned to either a sensorimotor physiotherapy group or a control group. The physiotherapy group received supervised exercises targeting pelvic floor activation, lumbopelvic motor control, sensory re-education, proprioceptive training, functional stabilization, and biofeedback-assisted training. The control group received standard postpartum education and home advice.

The main outcomes were pelvic motor control and perineal sensory function. Other outcomes included pelvic floor muscle strength, urinary symptoms, pelvic distress, core endurance, postural stability, pain intensity, and health-related quality of life. Outcomes were assessed at baseline, week 6, week 12, and week 24. The study aimed to determine whether structured sensorimotor physiotherapy provides greater benefits than standard postpartum advice and whether recovery patterns differ according to vaginal or cesarean delivery.

Studieoversikt

Detaljert beskrivelse

This was a prospective, single-center, assessor-blinded, stratified, parallel-group randomized controlled trial conducted in postpartum women. The study was designed to evaluate the effects of a structured 12-week exercise-based sensorimotor physiotherapy program on postpartum pelvic health, lumbopelvic motor control, sensory function, and functional recovery.

Eligible postpartum women were stratified according to delivery mode, vaginal delivery or cesarean delivery, and then randomly allocated to either the Sensorimotor Physiotherapy Group or the Control Group. The intervention group received supervised individual physiotherapy sessions twice weekly for 12 weeks, together with a structured home exercise program. The intervention included pelvic floor activation, lumbopelvic motor control training, proprioceptive exercises, sensory re-education, functional stabilization, and surface electromyography-assisted biofeedback. The control group received standard postpartum education and general home advice.

Outcome assessments were performed at baseline, week 6, week 12, and week 24 by blinded assessors. The primary focus was to determine whether the sensorimotor physiotherapy program improved pelvic motor control and perineal sensory function compared with standard postpartum advice. Secondary outcomes were used to evaluate broader functional and patient-reported recovery, including pelvic floor strength, urinary symptoms, pelvic distress, core endurance, postural stability, pain intensity, and health-related quality of life. Delivery mode was examined as an exploratory factor that could influence recovery patterns.

Studietype

Intervensjonell

Registrering (Faktiske)

160

Fase

  • Ikke aktuelt

Kontakter og plasseringer

Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.

Studiesteder

    • Kayseri
      • Kayseri, Kayseri, Tyrkia (Türkiye), 38130
        • Kayseri University

Deltakelseskriterier

Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.

Kvalifikasjonskriterier

Alder som er kvalifisert for studier

  • Voksen

Tar imot friske frivillige

Nei

Beskrivelse

Inclusion Criteria:

  • Women aged 18-40 years.
  • Postpartum women between 6 weeks and 6 months after delivery.
  • Singleton delivery.
  • Vaginal delivery or cesarean delivery.
  • Ability to understand and perform the required assessment procedures.
  • Ability to participate in the exercise-based intervention procedures.
  • Provision of written informed consent before enrollment.

Exclusion Criteria:

  • Third- or fourth-degree perineal tears.
  • Pelvic organ prolapse stage II or higher according to the POP-Q classification.
  • Active urinary tract infection or genital infection.
  • Previous pelvic or abdominal surgery unrelated to cesarean delivery.
  • Neurological conditions affecting lumbopelvic motor control.
  • Musculoskeletal conditions affecting lumbopelvic motor control.
  • Chronic pelvic pain syndromes.
  • Psychiatric disorders limiting participation.
  • Participation in structured physiotherapy or pelvic rehabilitation within the preceding 6 months.

Studieplan

Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.

Hvordan er studiet utformet?

Designdetaljer

  • Primært formål: Behandling
  • Tildeling: Randomisert
  • Intervensjonsmodell: Parallell tildeling
  • Masking: Enkelt

Våpen og intervensjoner

Deltakergruppe / Arm
Intervensjon / Behandling
Eksperimentell: Exercise-Based Sensorimotor Physiotherapy Program
A 12-week physiotherapist-led exercise-based sensorimotor physiotherapy program delivered individually twice weekly for approximately 45 minutes per session. The program included pelvic floor activation, diaphragmatic breathing, lumbopelvic motor control training, abdominal-pelvic floor synergy exercises, proprioceptive stimulation, tactile discrimination tasks, sensory re-education, functional stabilization, task-specific training, and surface electromyography-assisted biofeedback. Participants also completed a structured home exercise program for 15-20 minutes per day, five days per week.
A 12-week physiotherapist-led exercise-based sensorimotor physiotherapy program delivered individually twice weekly for approximately 45 minutes per session. The program included pelvic floor activation, diaphragmatic breathing, lumbopelvic motor control training, abdominal-pelvic floor synergy exercises, proprioceptive training, tactile discrimination tasks, sensory re-education, functional stabilization, task-specific training, and surface electromyography-assisted biofeedback. Participants also completed a structured home exercise program for 15-20 minutes per day, five days per week.
Andre navn:
  • Sensorimotor Physiotherapy
Annen: Standard Postpartum Education and Home Advice
A standard postpartum education and home advice program including information on postpartum anatomy, posture correction, bladder care, and general pelvic floor exercises. Participants received a printed home exercise leaflet and two telephone contacts at weeks 4 and 8 to encourage continuation of general advice. No supervised physiotherapy, individualized exercise progression, biofeedback, or structured sensorimotor training was provided.
A standard postpartum education and home advice program including information on postpartum anatomy, posture correction, bladder care, and general pelvic floor exercises. Participants received a printed home exercise leaflet and two telephone contacts at weeks 4 and 8 to encourage continuation of general advice. No supervised physiotherapy, individualized exercise progression, biofeedback, or structured sensorimotor training was provided.
Andre navn:
  • Standard Postpartum Advice

Hva måler studien?

Primære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Change in Pelvic Motor Control Composite Score
Tidsramme: Baseline, week 6, week 12, and week 24
Pelvic motor control was assessed using the Pelvic Motor Control Composite Score, an experimental composite index derived from surface electromyography-based parameters including normalized root mean square amplitude, onset latency, relaxation time, and contraction intermittency. Higher scores indicate better lumbopelvic motor control.
Baseline, week 6, week 12, and week 24
Change in Perineal Sensory Function
Tidsramme: Baseline, week 6, week 12, and week 24
Perineal sensory function was assessed using pressure detection threshold measured with a calibrated handheld algometer and two-point discrimination measured with a precision caliper. Lower values indicate better sensory responsiveness and tactile discrimination.
Baseline, week 6, week 12, and week 24

Sekundære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Change in Pelvic Floor Muscle Strength
Tidsramme: Baseline, week 6, week 12, and week 24
Pelvic floor muscle strength was assessed using the Modified Oxford Scale and the PERFECT scheme. Higher scores indicate greater pelvic floor muscle strength and function.
Baseline, week 6, week 12, and week 24
Change in Urinary Incontinence Severity
Tidsramme: Baseline, week 6, week 12, and week 24
Urinary incontinence severity was assessed using the International Consultation on Incontinence Questionnaire-Urinary Incontinence Short Form. Higher scores indicate greater urinary incontinence severity.
Baseline, week 6, week 12, and week 24
Change in Pelvic Floor Distress
Tidsramme: Baseline, week 6, week 12, and week 24
Pelvic floor-related distress was assessed using the Pelvic Floor Distress Inventory-20. Higher scores indicate greater pelvic floor symptom-related distress.
Baseline, week 6, week 12, and week 24
Change in Pelvic Floor Impact on Daily Function
Tidsramme: Baseline, week 6, week 12, and week 24
The functional impact of pelvic floor symptoms was assessed using the Pelvic Floor Impact Questionnaire-7. Higher scores indicate greater negative impact of pelvic floor symptoms on daily activities and quality of life.
Baseline, week 6, week 12, and week 24
Change in Core Endurance
Tidsramme: Baseline, week 6, week 12, and week 24
Core endurance was assessed using prone plank and side plank duration. Longer duration indicates better core endurance.
Baseline, week 6, week 12, and week 24
Change in Postural Stability
Tidsramme: Baseline, week 6, week 12, and week 24
Postural stability was assessed using center-of-pressure displacement during stabilometry. Lower center-of-pressure displacement or sway area indicates better postural stability.
Baseline, week 6, week 12, and week 24
Change in Pain Intensity
Tidsramme: Baseline, week 6, week 12, and week 24
Pain intensity was assessed using a 0-10 visual analogue scale. Higher scores indicate greater pain intensity.
Baseline, week 6, week 12, and week 24
Change in Health-Related Quality of Life
Tidsramme: Baseline, week 6, week 12, and week 24
Health-related quality of life was assessed using the 12-item Short Form Health Survey version 2. Higher scores indicate better perceived health-related quality of life.
Baseline, week 6, week 12, and week 24

Samarbeidspartnere og etterforskere

Det er her du vil finne personer og organisasjoner som er involvert i denne studien.

Etterforskere

  • Studiestol: Özge Çopuroğlu, Kayseri University

Studierekorddatoer

Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.

Studer hoveddatoer

Studiestart (Faktiske)

1. mars 2024

Primær fullføring (Faktiske)

1. desember 2025

Studiet fullført (Faktiske)

1. mars 2026

Datoer for studieregistrering

Først innsendt

9. juli 2026

Først innsendt som oppfylte QC-kriteriene

9. juli 2026

Først lagt ut (Faktiske)

14. juli 2026

Oppdateringer av studieposter

Sist oppdatering lagt ut (Faktiske)

14. juli 2026

Siste oppdatering sendt inn som oppfylte QC-kriteriene

9. juli 2026

Sist bekreftet

1. juli 2026

Mer informasjon

Begreper knyttet til denne studien

Plan for individuelle deltakerdata (IPD)

Planlegger du å dele individuelle deltakerdata (IPD)?

NEI

Legemiddel- og utstyrsinformasjon, studiedokumenter

Studerer et amerikansk FDA-regulert medikamentprodukt

Nei

Studerer et amerikansk FDA-regulert enhetsprodukt

Nei

Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .

Abonnere